WM Technology, Inc. Reports First Quarter 2026 Financial Results
Q1 2026 Revenue of
Sustains Consecutive Quarters of Adjusted EBITDA Profitability
“We are encouraged by the recent rescheduling of medical cannabis, which represents a meaningful federal step forward for the industry and for the millions of patients who rely on medical cannabis,” said
“Our first quarter results reflected steady execution, with revenue coming in ahead of our guidance range,” said
First Quarter 2026 Financial Highlights
-
Revenues for the first quarter ended
March 31, 2026 were$43.6 million as compared to$44.6 million in the prior year period. The decrease was primarily driven by continued softness across core markets, as challenging operating conditions for cannabis operators weighed on advertising spend.- Average monthly paying clients(1) of 4,983 decreased from 5,179 in the prior year period, largely due to churn in more established markets, partially offset by new client acquisitions across certain developing markets.
-
Average monthly revenues per paying client(2) increased to
$2,914 from$2,871 in the prior year period, primarily reflecting a positive mix impact from churn among clients with below-average spend levels.
-
Net income decreased to
$1.7 million from$2.5 million in the prior year period. -
Adjusted EBITDA(3) decreased to
$5.9 million from$10.1 million in the prior year period. -
Total shares outstanding across Class A and Class V Common Stock were 159.0 million as of
March 31, 2026 . -
Cash, cash equivalent and marketable securities increased to
$57.0 million as ofMarch 31, 2026 , as compared to$53.3 million as ofMarch 31, 2025 .
|
______________________________ |
|
Business Outlook
Based on information available as of
The guidance provided above is only an estimate of what we believe is realizable as of the date of this release. This guidance assumes that no business acquisitions, investments, restructurings, or legal settlements are concluded in the period. Our results are based on assumptions that we believe to be reasonable as of this date, but may be materially affected by many factors, as discussed below in “Forward-Looking Statements.” Actual results may vary from the guidance and the variations may be material. We undertake no intent or obligation to publicly update or revise any of these projections, whether as a result of new information, future events or otherwise, except as required by law.
Investor Conference Call and Webcasts
We will host a conference call and webcast today,
We have used, and intend to continue to use, the investor relations portion of our website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD.
About
Founded in 2008,
Over the past 18 years, the Weedmaps marketplace has become a premier destination for cannabis consumers to discover and browse cannabis-related products, access daily dispensary deals, order ahead for pick-up and delivery by participating retailers (where applicable) and learn about the plant. The Company also offers eCommerce-enablement tools designed to help cannabis retailers and brands reach consumers, create business efficiency, and manage industry-specific compliance needs.
Headquartered in
Forward-Looking Statements
This press release includes “forward-looking statements” regarding the Company’s future business expectations which involve risks and uncertainties. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial performance for the second quarter of 2026 and the potential impact of federal rescheduling of cannabis. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. These forward-looking statements are subject to a number of risks and uncertainties, including those related market reactions or impacts resulting from the Company’s delisting of its Class A Common Stock and warrants from the
Use of Non-GAAP Financial Measures
Our financial statements, including net income, are prepared in accordance with principles generally accepted in
To provide investors with additional information regarding our financial results, we have disclosed EBITDA and Adjusted EBITDA, both of which are non-GAAP financial measures that we calculate as net income before interest, taxes and depreciation and amortization expense in the case of EBITDA and further adjusted to exclude stock-based compensation, change in fair value of warrant liability, legal settlements and other legal costs, loss contingency, one-time asset sales, reduction in force expense, change in the TRA liability and other non-cash, unusual and/or infrequent costs in the case of Adjusted EBITDA. Below we have provided a reconciliation of net income (the most directly comparable GAAP financial measure) to EBITDA; and from EBITDA to Adjusted EBITDA.
We present EBITDA and Adjusted EBITDA because these metrics are a key measure used by our management to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of investment capacity. Accordingly, we believe that EBITDA and Adjusted EBITDA provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management.
Each of EBITDA and Adjusted EBITDA has limitations as an analytical tool, and you should not consider any of these non-GAAP financial measures in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are as follows:
- although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
- EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs; and
- EBITDA and Adjusted EBITDA do not reflect tax payments that may represent a reduction in cash available to us.
Because of these limitations, you should consider EBITDA and Adjusted EBITDA alongside other financial performance measures, including net income and our other GAAP results.
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands, except for share data) |
||||||||
|
|
|
|
|
|
||||
|
Assets |
|
|
|
|
||||
|
Current assets |
|
|
|
|
||||
|
Cash and cash equivalents |
|
$ |
45,519 |
|
|
$ |
62,401 |
|
|
Marketable securities |
|
|
11,483 |
|
|
|
— |
|
|
Accounts receivable, net |
|
|
16,863 |
|
|
|
14,619 |
|
|
Prepaid expenses and other current assets |
|
|
6,672 |
|
|
|
7,900 |
|
|
Total current assets |
|
|
80,537 |
|
|
|
84,920 |
|
|
Property and equipment, net |
|
|
25,530 |
|
|
|
24,986 |
|
|
|
|
|
61,274 |
|
|
|
61,274 |
|
|
Intangible assets, net |
|
|
1,369 |
|
|
|
1,510 |
|
|
Right-of-use assets |
|
|
11,631 |
|
|
|
12,219 |
|
|
Other assets |
|
|
6,067 |
|
|
|
5,758 |
|
|
Total assets |
|
$ |
186,408 |
|
|
$ |
190,667 |
|
|
Liabilities and Stockholders’ Equity |
|
|
|
|
||||
|
Current liabilities |
|
|
|
|
||||
|
Accounts payable and accrued expenses |
|
$ |
19,847 |
|
|
$ |
23,962 |
|
|
Deferred revenue |
|
|
5,999 |
|
|
|
5,499 |
|
|
Operating lease liabilities, current |
|
|
4,069 |
|
|
|
3,922 |
|
|
Tax receivable agreement liability, current |
|
|
— |
|
|
|
2,658 |
|
|
Warrant liability, current |
|
|
98 |
|
|
|
195 |
|
|
Total current liabilities |
|
|
30,013 |
|
|
|
36,236 |
|
|
Operating lease liabilities, non-current |
|
|
21,562 |
|
|
|
22,631 |
|
|
Total liabilities |
|
|
51,575 |
|
|
|
58,867 |
|
|
|
|
|
|
|
||||
|
Stockholders’ equity |
|
|
|
|
||||
|
Preferred Stock - |
|
|
— |
|
|
|
— |
|
|
Class A Common Stock - |
|
|
11 |
|
|
|
11 |
|
|
Class V Common Stock - |
|
|
5 |
|
|
|
5 |
|
|
Additional paid-in capital |
|
|
113,413 |
|
|
|
112,076 |
|
|
Accumulated other comprehensive income |
|
|
2 |
|
|
|
— |
|
|
Accumulated deficit |
|
|
(53,746 |
) |
|
|
(54,917 |
) |
|
|
|
|
59,685 |
|
|
|
57,175 |
|
|
Noncontrolling interests |
|
|
75,148 |
|
|
|
74,625 |
|
|
Total stockholders’ equity |
|
|
134,833 |
|
|
|
131,800 |
|
|
Total liabilities and stockholders’ equity |
|
$ |
186,408 |
|
|
$ |
190,667 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In thousands, except for share data) |
|||||||
|
|
Three Months Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Revenues |
$ |
43,558 |
|
$ |
44,612 |
|
|
|
|
|
|
|
||||
|
Costs and expenses |
|
|
|
||||
|
Cost of revenues (exclusive of depreciation and amortization shown separately below) |
|
2,204 |
|
|
|
2,241 |
|
|
Sales and marketing |
|
10,302 |
|
|
|
10,017 |
|
|
Product development |
|
8,733 |
|
|
|
9,720 |
|
|
General and administrative |
|
19,060 |
|
|
|
16,666 |
|
|
Depreciation and amortization |
|
3,060 |
|
|
|
3,321 |
|
|
Total costs and expenses |
|
43,359 |
|
|
|
41,965 |
|
|
Operating income |
|
199 |
|
|
|
2,647 |
|
|
Other income (expenses), net |
|
|
|
||||
|
Change in fair value of warrant liability |
|
97 |
|
|
|
— |
|
|
Change in tax receivable agreement liability |
|
— |
|
|
|
(545 |
) |
|
Other income |
|
1,430 |
|
|
|
401 |
|
|
Income before income taxes |
|
1,726 |
|
|
|
2,503 |
|
|
Provision for income taxes |
|
32 |
|
|
|
9 |
|
|
Net income |
|
1,694 |
|
|
|
2,494 |
|
|
Net income attributable to noncontrolling interests |
|
523 |
|
|
|
847 |
|
|
Net income attributable to |
$ |
1,171 |
|
|
$ |
1,647 |
|
|
|
|
|
|
||||
|
Class A Common Stock: |
|
|
|
||||
|
Basic income per share |
$ |
0.01 |
|
|
$ |
0.02 |
|
|
Diluted income per share |
$ |
0.01 |
|
|
$ |
0.02 |
|
|
|
|
|
|
||||
|
Class A Common Stock: |
|
|
|
||||
|
Weighted average basic shares outstanding |
|
110,588,979 |
|
|
|
104,041,260 |
|
|
Weighted average diluted shares outstanding |
|
110,801,379 |
|
|
|
106,991,698 |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In thousands) |
|||||||
|
|
Three Months Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Cash flows from operating activities |
|
|
|
||||
|
Net income |
$ |
1,694 |
|
|
$ |
2,494 |
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
|
||||
|
Depreciation and amortization |
|
3,060 |
|
|
|
3,321 |
|
|
Change in fair value of warrant liability |
|
(97 |
) |
|
|
— |
|
|
Change in tax receivable agreement liability |
|
— |
|
|
|
545 |
|
|
Amortization of right-of-use lease assets |
|
588 |
|
|
|
643 |
|
|
Gain on sale of domain name |
|
(1,000 |
) |
|
|
— |
|
|
Stock-based compensation |
|
1,317 |
|
|
|
2,194 |
|
|
Loss contingency |
|
(245 |
) |
|
|
— |
|
|
Other reconciling items included in net income |
|
7 |
|
|
|
— |
|
|
Provision for credit losses |
|
3,939 |
|
|
|
314 |
|
|
Changes in operating assets and liabilities: |
|
|
|
||||
|
Accounts receivable |
|
(6,184 |
) |
|
|
(935 |
) |
|
Prepaid expenses and other current assets |
|
1,228 |
|
|
|
(582 |
) |
|
Other assets |
|
(397 |
) |
|
|
67 |
|
|
Accounts payable and accrued expenses |
|
(4,777 |
) |
|
|
(1,133 |
) |
|
Deferred revenue |
|
500 |
|
|
|
(404 |
) |
|
Operating lease liabilities |
|
(922 |
) |
|
|
(860 |
) |
|
Net cash provided by (used in) operating activities |
|
(1,289 |
) |
|
|
5,664 |
|
|
|
|
|
|
||||
|
Cash flows used in investing activities |
|
|
|
||||
|
Capitalized software and expenditures |
|
(2,535 |
) |
|
|
(3,650 |
) |
|
Purchase of marketable securities |
|
(11,488 |
) |
|
|
— |
|
|
Proceeds from sale of domain name |
|
1,000 |
|
|
|
— |
|
|
Net cash used in investing activities |
|
(13,023 |
) |
|
|
(3,650 |
) |
|
|
|
|
|
||||
|
Cash flows used in financing activities |
|
|
|
||||
|
Distributions |
|
— |
|
|
|
(704 |
) |
|
Proceeds from repayment of related party note |
|
89 |
|
|
|
— |
|
|
Taxes paid related to net share settlement of equity awards |
|
— |
|
|
|
(1 |
) |
|
Tax receivable agreement payment |
|
(2,659 |
) |
|
|
— |
|
|
Net cash used in financing activities |
|
(2,570 |
) |
|
|
(705 |
) |
|
|
|
|
|
||||
|
Net increase (decrease) in cash |
|
(16,882 |
) |
|
|
1,309 |
|
|
Cash and cash equivalents – beginning of period |
|
62,401 |
|
|
|
51,966 |
|
|
Cash and cash equivalents – end of period |
$ |
45,519 |
|
|
$ |
53,275 |
|
|
RECONCILIATION OF NET INCOME TO EBITDA AND ADJUSTED EBITDA (Unaudited) (In thousands) |
|||||||
|
|
Three Months Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
|
(in thousands) |
||||||
|
Net income |
$ |
1,694 |
|
|
$ |
2,494 |
|
|
Provision for income taxes |
|
32 |
|
|
|
9 |
|
|
Depreciation and amortization expenses |
|
3,060 |
|
|
|
3,321 |
|
|
Interest income |
|
(491 |
) |
|
|
(409 |
) |
|
EBITDA |
|
4,295 |
|
|
|
5,415 |
|
|
Stock-based compensation |
|
1,317 |
|
|
|
2,194 |
|
|
Change in fair value of warrant liability |
|
(97 |
) |
|
|
— |
|
|
Sale of domain name |
|
(1,000 |
) |
|
|
— |
|
|
Legal settlements and other legal costs(1) |
|
648 |
|
|
|
1,104 |
|
|
Reduction in force expense(2) |
|
939 |
|
|
|
879 |
|
|
Loss contingency |
|
(245 |
) |
|
|
— |
|
|
Change in tax receivable agreement liability |
|
— |
|
|
|
545 |
|
|
Adjusted EBITDA |
$ |
5,857 |
|
|
$ |
10,137 |
|
|
1 |
Represents legal and advisory fees related to ongoing litigation related to shareholder derivative actions. See Note 5, “Commitments and Contingencies” of our condensed consolidated financial statement included in the Form 10-Q for the period ended |
|
|
2 |
Represents severance charges related to certain reduction in force actions taken by our management. These reduction in force actions are designed to enhance operational efficiency and align resources with strategic priorities in our corporate technology and marketing divisions. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260511406353/en/
Investor Relations:
investors@weedmaps.com
Media Contract:
press@weedmaps.com
Source: